Compare STRO & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRO | NREF |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 244.2M |
| IPO Year | N/A | N/A |
| Metric | STRO | NREF |
|---|---|---|
| Price | $23.38 | $13.23 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $18.88 | $14.50 |
| AVG Volume (30 Days) | ★ 127.8K | 43.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $63.08 | $24.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $12.14 |
| 52 Week High | $27.96 | $16.80 |
| Indicator | STRO | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 63.80 | 28.00 |
| Support Level | $0.76 | $12.36 |
| Resistance Level | N/A | $15.25 |
| Average True Range (ATR) | 2.05 | 0.42 |
| MACD | 0.14 | -0.12 |
| Stochastic Oscillator | 52.91 | 5.45 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.